# First Financial Bancorp: financial statements, quarterly

FFBC · Nasdaq · CIK 708955 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ffbc.md) · [Financials](/companies/ffbc/financials.md) · [Filings](/companies/ffbc/filings.md) · [Insiders](/companies/ffbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ffbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [76.6](/filings/0000708955-23-000057.md) | [84.7 d](/filings/0000708955-24-000018.md) | [91.9](/filings/0000708955-24-000028.md) | [99.4](/filings/0000708955-24-000051.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [15.3](/filings/0000708955-24-000063.md) | [14.7 d](/filings/0000708955-26-000028.md) | [11.0](/filings/0000708955-25-000038.md) | [14.0](/filings/0000708955-25-000070.md) | [12.4](/filings/0000708955-25-000109.md) | [2.0 d](/filings/0000708955-26-000028.md) | [12.3](/filings/0000708955-26-000096.md) | [17.9](/filings/0000708955-26-000144.md) | [18.8](/filings/0000708955-25-000109.md) | [16.7 d](/filings/0000708955-26-000028.md) | [19.1](/filings/0000708955-26-000096.md) | [18.0](/filings/0000708955-26-000144.md) |
| Net income | $m | [63.1](/filings/0000708955-24-000063.md) | [56.7 d](/filings/0000708955-26-000028.md) | [50.7](/filings/0000708955-25-000038.md) | [60.8](/filings/0000708955-25-000070.md) | [52.5](/filings/0000708955-25-000109.md) | [64.9 d](/filings/0000708955-26-000028.md) | [51.3](/filings/0000708955-26-000096.md) | [70.0](/filings/0000708955-26-000144.md) | [71.9](/filings/0000708955-25-000109.md) | [62.4 d](/filings/0000708955-26-000028.md) | [74.4](/filings/0000708955-26-000096.md) | [76.5](/filings/0000708955-26-000144.md) |
| Diluted EPS | $ per share | [0.66](/filings/0000708955-24-000063.md) | not reported | [0.53](/filings/0000708955-25-000038.md) | [0.64](/filings/0000708955-25-000070.md) | [0.55](/filings/0000708955-25-000109.md) | not reported | [0.54](/filings/0000708955-26-000096.md) | [0.73](/filings/0000708955-26-000144.md) | [0.75](/filings/0000708955-25-000109.md) | not reported | [0.71](/filings/0000708955-26-000096.md) | [0.73](/filings/0000708955-26-000144.md) |
| Basic EPS | $ per share | [0.67](/filings/0000708955-24-000063.md) | not reported | [0.54](/filings/0000708955-25-000038.md) | [0.64](/filings/0000708955-25-000070.md) | [0.56](/filings/0000708955-25-000109.md) | not reported | [0.54](/filings/0000708955-26-000096.md) | [0.74](/filings/0000708955-26-000144.md) | [0.76](/filings/0000708955-25-000109.md) | not reported | [0.72](/filings/0000708955-26-000096.md) | [0.74](/filings/0000708955-26-000144.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [17.1](/filings/0000708955-23-000057.md) | [17.5](/filings/0000708955-25-000012.md) | [17.6](/filings/0000708955-24-000028.md) | [18.2](/filings/0000708955-24-000051.md) | [18.1](/filings/0000708955-24-000063.md) | [18.6](/filings/0000708955-26-000028.md) | [18.5](/filings/0000708955-25-000038.md) | [18.6](/filings/0000708955-25-000070.md) | [18.6](/filings/0000708955-25-000109.md) | [21.1](/filings/0000708955-26-000144.md) | [22.8](/filings/0000708955-26-000096.md) | [22.4](/filings/0000708955-26-000144.md) |
| Total liabilities | $bn | [14.9](/filings/0000708955-23-000057.md) | [15.3](/filings/0000708955-25-000012.md) | [15.3](/filings/0000708955-24-000028.md) | [15.8](/filings/0000708955-24-000051.md) | [15.7](/filings/0000708955-24-000063.md) | [16.1](/filings/0000708955-26-000028.md) | [16.0](/filings/0000708955-25-000038.md) | [16.1](/filings/0000708955-25-000070.md) | [15.9](/filings/0000708955-25-000109.md) | [18.4](/filings/0000708955-26-000144.md) | [19.8](/filings/0000708955-26-000096.md) | [19.5](/filings/0000708955-26-000144.md) |
| Long-term debt | $bn | [0.3](/filings/0000708955-23-000057.md) | [0.3](/filings/0000708955-25-000012.md) | [0.3](/filings/0000708955-24-000028.md) | [0.3](/filings/0000708955-24-000051.md) | [0.3](/filings/0000708955-24-000063.md) | [0.3](/filings/0000708955-26-000028.md) | [0.3](/filings/0000708955-25-000038.md) | [0.3](/filings/0000708955-25-000070.md) | [0.2](/filings/0000708955-25-000109.md) | [0.5](/filings/0000708955-26-000144.md) | [0.4](/filings/0000708955-26-000096.md) | [0.4](/filings/0000708955-26-000144.md) |
| Short-term borrowings | $bn | [1.0](/filings/0000708955-23-000057.md) | [0.9](/filings/0000708955-26-000028.md) | [0.9](/filings/0000708955-24-000028.md) | [1.2](/filings/0000708955-24-000051.md) | [0.8](/filings/0000708955-24-000063.md) | [0.8](/filings/0000708955-26-000028.md) | [0.8](/filings/0000708955-25-000038.md) | [0.7](/filings/0000708955-25-000070.md) | [0.6](/filings/0000708955-25-000109.md) | [0.7](/filings/0000708955-26-000144.md) | [0.6](/filings/0000708955-26-000096.md) | [0.6](/filings/0000708955-26-000144.md) |
| Shareholders' equity | $bn | [2.1](/filings/0000708955-24-000063.md) | [2.3](/filings/0000708955-26-000028.md) | [2.3](/filings/0000708955-25-000070.md) | [2.3](/filings/0000708955-25-000109.md) | [2.5](/filings/0000708955-25-000109.md) | [2.4](/filings/0000708955-26-000144.md) | [2.5](/filings/0000708955-26-000144.md) | [2.6](/filings/0000708955-26-000144.md) | [2.6](/filings/0000708955-25-000109.md) | [2.8](/filings/0000708955-26-000144.md) | [2.9](/filings/0000708955-26-000144.md) | [3.0](/filings/0000708955-26-000144.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [91.7 d](/filings/0000708955-24-000063.md) | [116 d](/filings/0000708955-26-000028.md) | [31.9](/filings/0000708955-25-000038.md) | [68.1 d](/filings/0000708955-25-000070.md) | [88.1 d](/filings/0000708955-25-000109.md) | [74.1 d](/filings/0000708955-26-000028.md) | [56.1](/filings/0000708955-26-000096.md) | [69.8 d](/filings/0000708955-26-000144.md) | [89.8 d](/filings/0000708955-25-000109.md) | [122 d](/filings/0000708955-26-000028.md) | [549](/filings/0000708955-26-000096.md) | [31.4 d](/filings/0000708955-26-000144.md) |
| Capital expenditure | $m | [6.1 d](/filings/0000708955-24-000063.md) | [6.0 d](/filings/0000708955-26-000028.md) | [7.1](/filings/0000708955-25-000038.md) | [3.3 d](/filings/0000708955-25-000070.md) | [3.7 d](/filings/0000708955-25-000109.md) | [7.0 d](/filings/0000708955-26-000028.md) | [3.8](/filings/0000708955-26-000096.md) | [4.9 d](/filings/0000708955-26-000144.md) | [4.0 d](/filings/0000708955-25-000109.md) | [8.0 d](/filings/0000708955-26-000028.md) | [13.5](/filings/0000708955-26-000096.md) | [10.3 d](/filings/0000708955-26-000144.md) |
| Dividends paid | $m | [21.8 d](/filings/0000708955-24-000063.md) | [21.7 d](/filings/0000708955-26-000028.md) | [21.9](/filings/0000708955-25-000038.md) | [22.4 d](/filings/0000708955-25-000070.md) | [22.7 d](/filings/0000708955-25-000109.md) | [22.7 d](/filings/0000708955-26-000028.md) | [23.0](/filings/0000708955-26-000096.md) | [23.6 d](/filings/0000708955-26-000144.md) | [23.7 d](/filings/0000708955-25-000109.md) | [24.4 d](/filings/0000708955-26-000028.md) | [26.0](/filings/0000708955-26-000096.md) | [26.9 d](/filings/0000708955-26-000144.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [94.8](/filings/0000708955-23-000057.md) | [95.0](/filings/0000708955-24-000028.md) | [95.2](/filings/0000708955-24-000051.md) | [95.1](/filings/0000708955-24-000063.md) | [95.2](/filings/0000708955-25-000038.md) | [95.5](/filings/0000708955-25-000070.md) | [95.5](/filings/0000708955-25-000109.md) | [95.5](/filings/0000708955-26-000096.md) | [95.7](/filings/0000708955-26-000144.md) | [95.8](/filings/0000708955-25-000109.md) | [105](/filings/0000708955-26-000096.md) | [105](/filings/0000708955-26-000144.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 104,968,940 at 2026-08-05, from the cover of the [10-Q filed 2026-08-06](/filings/0000708955-26-000144.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.